MDMA History and Legality with Natalie Ginsberg

MDMA History and Legality with Natalie Ginsberg

Natalie Ginsberg is the director of policy and advocacy at the Multidisciplinary Association for Psychadelic Studies (MAPS). She works hard to disentangle science from political partisanship on Capitol Hill, the United Nations, and beyond. Today, she is joining us to discuss the history and current legality of MDMA.

Unlike many other psychedelics, MDMA was actually legal in the United States for quite some time. It was originally developed in 1912 in an attempt by pharmaceuticals to create a blood-clotting agent. Later on, MDMA was redeveloped with attention paid to its potential therapeutic effects. Consequently, throughout the 1970s, MDMA was widely in therapy, particularly to address phobias and in couples therapy.

This all changed in the early 1980s when MDMA found its way into the club scene. With the War on Drugs in full swing, the federal government, despite lobbying efforts by therapists, religious leaders, and activists, classified it as a Schedule 1 drug.

There are now efforts underway by MAPS and other organizations to get MDMA back on a pathway for legalization. By citing government studies, collecting anecdotes, and running phase 1 and phase 2 studies, MAPS has shown that there is great potential for a rescheduling of this drug.

In this episode:
  • How MDMA was first used in a therapeutic setting
  • The history of how MDMA became criminalized
  • Current efforts to reclassify MDMA as a medicine
  • Evidence that MDMA can be used to successfully treat PTSD
  • What may happen to the legal status of MDMA if it is rescheduled
  • Ways in which psychedelics are used in conflict resolution settings

Quotes:

"Throughout the 70s, MDMA was actually used across the US and the world in therapy." [3:20]

"Something that we were able to do was use the abundance of MDMA research that governments had sponsored to try to demonstrate harm but had actually demonstrated safety." [12:20]

"Everyone who we interviewed had a very clear intention with the process of taking it for self-healing. They weren't going to save the world to do conflict resolution." [25:43]

Links:

MAPS

Follow Natalie on Instagram

Check out the full episode post

Keep up with everything Plant Medicine related here

Porangui

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(209)

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

In this episode of the Psychedelic Medicine Podcast, Nigel Denning, MA, MPsych, joins to discuss the reasons profound psychedelic experiences don't always lead to lasting change. Nigel is a Counsellin...

9 Sep 35min

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

In this episode of the Psychedelic Medicine Podcast, Fernando Rivas, MD, joins to unpack the safety and screening considerations for ibogaine therapy. Dr. Rivas is an emergency physician with over 15 ...

27 Aug 39min

Encore Episode: Psychedelics and Breathwork with Kyle Buller

Encore Episode: Psychedelics and Breathwork with Kyle Buller

This encore episode of the Psychdelic Medicine Podcast features a conversation with Kyle Buller on psychedelics and breathwork. Kyle is co-founder and host of the Psychedelics Today podcast and he has...

13 Aug 43min

Psychedelics and Psychosis with Alexander Lebedev, MD, PhD

Psychedelics and Psychosis with Alexander Lebedev, MD, PhD

In this episode of the Psychedelic Medicine Podcast, Alexander Lebedev, MD, PhD joins to discuss psychedelic medicine and psychosis. Dr. Lebedev is a physician-scientist, medical AI engineer, and entr...

30 Juli 46min

Psychedelics and GLP-1s with Arsalan Azam, MD

Psychedelics and GLP-1s with Arsalan Azam, MD

In this episode of the Psychedelic Medicine Podcast, Arsalan Azam, MD joins to unpack the intersection between psychedelics and GLP-1s. Dr. Azam, founder of Daydream MD, completed his residency in Eme...

14 Juli 36min

Psilocybin vs. Ketamine with Dori Lewis, LPC

Psilocybin vs. Ketamine with Dori Lewis, LPC

In this episode of the Psychedelic Medicine Podcast, Dori Lewis, MA, MEd, LPC-S returns to discuss the differences between psilocybin and ketamine. Dori is the Clinical Director of Elemental Psychedel...

2 Juli 43min

Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD

Choosing the Right Ketamine Clinic for You with Katie Fassbinder, MD

In this episode of the Psychedelic Medicine Podcast, Katie Fassbinder, MD joins to explore how to choose the right ketamine clinic. Dr. Fassbinder is the Faculty Medical Lead for ketamine-assisted psy...

11 Juni 50min

The Future of Psychedelic Medicine with Ismail Lourido Ali, JD

The Future of Psychedelic Medicine with Ismail Lourido Ali, JD

In the 200th episode of the Psychedelic Medicine Podcast, Ismail Lourido Ali, JD joins to discuss the future of psychedelic medicine. Ismail serves as MAPS Co-Executive Director and has been actively ...

28 Maj 52min

Populärt inom Hälsa

somna-med-henrik
rss-jossan-nina
rss-bara-en-till-om-beroende-medberoende
inga-beiga-morsor
rss-vuxna-pa-latsas
bullfika
johannes-hansen-podcast
angestpodden
rss-viktmedicinpodden
sexnoveller-deluxe
sova-med-dan-horning
sa-in-i-sjalen
rss-ronden
not-fanny-anymore
tyngre-traningssnack
rss-traningsklubben
rss-basta-livet
halsoveckan-by-tyngre
rss-hos-psykologen
rss-sjalsligt-avkladd